128940.KS
Hanmi Pharm. Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 460,500.00
−2.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 22.17x
- P/E 2027E
- 25.64x
- P/E 2028E
- 26.79x
- P/S forward
- 3.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.87x
- PEG TTM
- 0.36x
- Price / book
- 4.72x
- Price / sales
- 4.00x
- Price / cash flow
- 24.54x
Enterprise value
- Enterprise value
- KRW 6.82T
- EV / sales
- 4.12x
- EV / EBITDA
- 17.95x
- EV / EBIT
- 24.44x
- Market cap
- KRW 6.62T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026